Skip to main content
Log in

Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschênes SS [letter]

  • Letter
  • Published:
Diabetologia Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abbreviations

QoL:

Quality of life

WHO-5:

WHO-5 Well-Being Index

References

  1. Pouwer F, Deschênes SS (2024) Critical comments regarding the clinical impact of the POWER2DM intervention. Diabetologia. https://doi.org/10.1007/s00125-024-06117-4

  2. Ruissen MM, Torres-Peña JD, Uitbeijerse BS et al (2023) Clinical impact of an integrated e-health system for diabetes self-management support and shared decision making (POWER2DM): a randomised controlled trial. Diabetologia 66(12):2213–2225. https://doi.org/10.1007/s00125-023-06006-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Topp CW, Østergaard SD, Søndergaard S, Bech P (2015) The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom 84(3):167–176. https://doi.org/10.1159/000376585

    Article  PubMed  Google Scholar 

  4. Bech P, Lunde M, Bech-Andersen G, Lindberg L, Martiny K (2007) Psychiatric outcome studies (POS): does treatment help the patients? A Popperian approach to research in clinical psychiatry. Nord J Psychiatry 61(Suppl 46):4–34. https://doi.org/10.1080/08039480601151238

    Article  PubMed  Google Scholar 

  5. Sedaghat AR (2019) Understanding the minimal clinically important difference (MCID) of patient-reported outcome measures. Otolaryngol Head Neck Surg 161(4):551–560. https://doi.org/10.1177/0194599819852604

    Article  PubMed  Google Scholar 

  6. Coretti S, Ruggeri M, McNamee P (2014) The minimum clinically important difference for EQ-5D index: a critical review. Expert Rev Pharmacoecon Outcomes Res 14(2):221–233. https://doi.org/10.1586/14737167.2014.894462

    Article  PubMed  Google Scholar 

  7. Glachs D, Namli T, Strohmeier F et al (2021) A predictive model-based decision support system for diabetes patient empowerment. Stud Health Technol Inform 281:963–968. https://doi.org/10.3233/SHTI210321

    Article  PubMed  Google Scholar 

  8. Jung O, Glachs D, Strohmeier F (2019) Empowering diabetes patients with interventions based on behaviour change techniques. Stud Health Technol Inform 260:154–161

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jacob K. Sont.

Ethics declarations

Authors’ relationships and activities

The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.

Contribution statement

All authors were responsible for drafting the article and reviewing it critically for important intellectual content. All authors approved the version to be published.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ruissen, M.M., Steyerberg, E.W., Huisman, S.D. et al. Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschênes SS [letter]. Diabetologia 67, 956–957 (2024). https://doi.org/10.1007/s00125-024-06119-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00125-024-06119-2

Keywords

Navigation